Auvi-Q® (epinephrine) – Expanded indication
November 20, 2017 – Kaleo announced the FDA approval of Auvi-Q (epinephrine) injection for emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (eg, order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (eg, triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (eg, radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis in patients weighing 7.5 to 15 kg (16.5 to 33 lbs).
Top